Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?

Detalles Bibliográficos
Autores principales: Bahçecíoğlu, Ömer Faruk, Gök, Selim, Durmuş, Mefküre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
PostScript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907691/
https://www.ncbi.nlm.nih.gov/pubmed/33472816
http://dx.doi.org/10.1136/ejhpharm-2021-002680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907691/
https://www.ncbi.nlm.nih.gov/pubmed/33472816
http://dx.doi.org/10.1136/ejhpharm-2021-002680

Ejemplares similares